Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2025 Filed Jul 2, 2025 18:21 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 136 $242.82 $33,022.84
Disclosure

SEC source: 0001062993-25-012434 · form4.xml · derivative · entry 3

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254

Underlying: Humana Common · 136 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 15:53 UTC GrantRestricted Stock Units · Derivative 76 $242.82 $18,453.94
Disclosure

SEC source: 0001062993-25-012426 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 569

Underlying: Humana Common · 76 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
May 14, 2025 Filed May 16, 2025 20:48 UTC
Rechtin James A.President & CEO
PurchaseHumana Common 6,530 $229.25 $1,496,983.56
Disclosure

SEC source: 0001062993-25-009705 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 30,474

F7 · price: Average price of shares purchased in reported transaction.

F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 17:46 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 118 $263.88 $31,137.25
Disclosure

SEC source: 0001062993-25-006787 · form4.xml · derivative · entry 3

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118

Underlying: Humana Common · 118 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 17:45 UTC GrantRestricted Stock Units · Derivative 345 $263.88 $91,036.88
Disclosure

SEC source: 0001062993-25-006786 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,645

Underlying: Humana Common · 345 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 17:44 UTC GrantRestricted Stock Units · Derivative 66 $263.88 $17,415.75
Disclosure

SEC source: 0001062993-25-006785 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493

Underlying: Humana Common · 66 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 11:57 UTC
Renaudin George IIPresident, Insurance
OtherPhantom Stock Units · Derivative 5 $270.38 $1,351.90
Disclosure

SEC source: 0001062993-25-006535 · form4.xml · derivative · entry 7

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 170

Underlying: Humana Common · 5 shares

Expires not disclosed

F8 · security: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F8 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F8 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F8 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F8 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
February 24, 2025 Filed Feb 25, 2025 20:11 UTC
Dintenfass DavidPresident, Enterprise Growth
GrantHumana Common 4,360 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 2

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,234

F2 · balance_after: Includes 13,234 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 25, 2025 18:49 UTC
Agrawal VishalChief Strat & Corp Dev Officer
GrantHumana Common 3,270 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 3

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,717

F12 · balance_after: Includes 4,178 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 25, 2025 18:11 UTC
Renaudin George IIPresident, Insurance
GrantHumana Common 4,516 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 3

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,702

F7 · balance_after: Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 25, 2025 18:08 UTC
Ventura Joseph CChief Legal Officer
GrantHumana Common 4,438 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 3

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,267

F9 · balance_after: Includes 8,296 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 21:21 UTC
Mehta JapanChief Information Officer
GrantHumana Common 3,582 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003657 · form4.xml · nonDerivative · entry 1

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,628

F1 · balance_after: Includes 8,628 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 20:50 UTC
Shetty Sanjay KPresident, CenterWell
GrantHumana Common 4,205 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003616 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,566

F5 · balance_after: Includes 10,786 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 20:40 UTC
O'Hara Michelle A.Chief Human Resources Officer
GrantHumana Common 4,205 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003612 · form4.xml · nonDerivative · entry 1

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,266

F1 · balance_after: Includes 11,266 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 15:19 UTC
Rechtin James A.President & CEO
GrantHumana Common 19,037 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003577 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 23,944

F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 14:58 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
GrantHumana Common 876 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003569 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,767

F4 · balance_after: Includes 1,203 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 14:38 UTC
Mellet CelesteChief Financial Officer
GrantHumana Common 6,385 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003567 · form4.xml · nonDerivative · entry 1

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,676

F1 · balance_after: Includes 29,676 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 20:11 UTC
Dintenfass DavidPresident, Enterprise Growth
Tax withholdingHumana Common 1,175 $258.58 $303,825.63
Disclosure

SEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 1

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,874

F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/25.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:49 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Tax withholdingHumana Common 905 $258.58 $234,010.38
Disclosure

SEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 2

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,447

F11 · shares: Disposition reported represents shares withheld for payment of tax liability on Performance Stock units vested on 2/21/25.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:49 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionHumana Common 1,970 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 1

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:11 UTC
Renaudin George IIPresident, Insurance
Tax withholdingHumana Common 300 $258.58 $77,572.50
Disclosure

SEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,186

F9 · shares: Shares disposed of represent payment for tax liability for Performance Stock units vested on 2/21/25.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:11 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionHumana Common 732 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,486

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:08 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 1,065 $258.58 $275,382.38
Disclosure

SEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,829

F10 · shares: Shares disposed of represent payment for tax liability on Performance Stock Units vested on 2/21/25.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 18:08 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 2,308 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 15:26 UTC
Mellet CelesteChief Financial Officer
GrantHumana Common 23,291 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-002637 · form4.xml · nonDerivative · entry 1

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,291

F1 · balance_after: Includes 23,291 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 14:58 UTC
Mehta JapanChief Information Officer
GrantHumana Common 5,046 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-002633 · form4.xml · nonDerivative · entry 1

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,046

F1 · balance_after: Includes 5,046 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 16:47 UTC
Rechtin James A.President & CEO
Exercise / conversionRestricted Stock Units · Derivative 2,182 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000655 · form4.xml · derivative · entry 5

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,366

Underlying: Humana Common · 2,182 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 16:47 UTC
Rechtin James A.President & CEO
Tax withholdingHumana Common 978 $264.68 $258,857.04
Disclosure

SEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 2

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,907

F7 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 1/8/25.

F6 · balance_after: Includes 2,724 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 16:47 UTC
Rechtin James A.President & CEO
Exercise / conversionHumana Common 2,182 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 21:48 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000214 · form4.xml · derivative · entry 2

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,005

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 21:46 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000210 · form4.xml · derivative · entry 2

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,408

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 18:42 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000103 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,060

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 18:29 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000099 · form4.xml · derivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,861

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

Read SEC document
January 02, 2025 Filed Jan 3, 2025 18:26 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000097 · form4.xml · derivative · entry 2

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,034

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 18:09 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000091 · form4.xml · derivative · entry 2

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 783

Underlying: Humana Common · 783 shares

Expires not disclosed

F2 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 15:53 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000058 · form4.xml · derivative · entry 2

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,408

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 15:30 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000054 · form4.xml · derivative · entry 2

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,163

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 15:12 UTC GrantRestricted Stock Units · Derivative 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000050 · form4.xml · derivative · entry 2

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,593

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 15:10 UTC
SMITH BRAD DDirector
GrantHumana Common 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000048 · form4.xml · nonDerivative · entry 1

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,169

F4 · balance_after: Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 15:08 UTC GrantHumana Common 783 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000046 · form4.xml · nonDerivative · entry 1

Mesquita Jorge S. · CIK 0001547344 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 3,361

F1 · balance_after: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

F1 · ownership.nature: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 18:33 UTC
O'Hara Michelle A.Chief Human Resources Officer
GrantHumana Common 7,061 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000101 · form4.xml · nonDerivative · entry 1

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,061

F1 · balance_after: Includes 7,061 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:48 UTC GrantRestricted Stock Units · Derivative 17 $254.93 $4,333.81
Disclosure

SEC source: 0001062993-25-000214 · form4.xml · derivative · entry 3

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25

Underlying: Humana Common · 17 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:46 UTC GrantRestricted Stock Units · Derivative 23 $254.93 $5,863.39
Disclosure

SEC source: 0001062993-25-000210 · form4.xml · derivative · entry 3

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38

Underlying: Humana Common · 23 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2024 Filed Jan 3, 2025 18:29 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 38 $254.93 $9,687.34
Disclosure

SEC source: 0001062993-25-000099 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75

Underlying: Humana Common · 38 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2024 Filed Jan 3, 2025 18:26 UTC GrantRestricted Stock Units · Derivative 673 $254.93 $171,567.89
Disclosure

SEC source: 0001062993-25-000097 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,300

Underlying: Humana Common · 673 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 18:26 UTC GrantRestricted Stock Units · Derivative 565 $254.93 $144,035.45
Disclosure

SEC source: 0001062993-25-000097 · form4.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,753

Underlying: Humana Common · 565 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2024 Filed Jan 3, 2025 18:11 UTC
Diamond Susan MChief Financial Officer
OtherPhantom Stock Units · Derivative 1 $260.73 $260.73
Disclosure

SEC source: 0001062993-25-000093 · form4.xml · derivative · entry 9

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote.

Disclosed balance after: 332

Underlying: Humana Common · 1 shares

Expires not disclosed

F10 · security: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024.

F10 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024.

F10 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024.

F10 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024.

F10 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 15:53 UTC GrantRestricted Stock Units · Derivative 23 $254.93 $5,863.39
Disclosure

SEC source: 0001062993-25-000058 · form4.xml · derivative · entry 3

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38

Underlying: Humana Common · 23 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2024 Filed Jan 3, 2025 15:51 UTC
Huval Timothy S.Chief Administrative Officer
GiftHumana Common 1,070 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-000056 · form4.xml · nonDerivative · entry 2

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,111

F11 · shares: Shares disposed of represent gift/charitable donation in which no value was received in return.

F9 · balance_after: Includes 3,813 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 15:51 UTC
Huval Timothy S.Chief Administrative Officer
SaleHumana Common 3,703 $256.26 $948,925.23
Disclosure

SEC source: 0001062993-25-000056 · form4.xml · nonDerivative · entry 1

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,181

F10 · price: All shares sold at reported price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.